These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9557608)

  • 1. Drug resistance in multiple myeloma: cyclosporin A analogues and their metabolites as potential chemosensitizers.
    Pilarski LM; Yatscoff RW; Murphy GF; Belch AR
    Leukemia; 1998 Apr; 12(4):505-9. PubMed ID: 9557608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SDZ PSC-833--a novel potent in vitro chemosensitizer in multiple myeloma.
    Jonsson B; Nilsson K; Nygren P; Larsson R
    Anticancer Drugs; 1992 Dec; 3(6):641-6. PubMed ID: 1363199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficient drug transporter function of bone marrow-localized and leukemic plasma cells in multiple myeloma.
    Pilarski LM; Szczepek AJ; Belch AR
    Blood; 1997 Nov; 90(9):3751-9. PubMed ID: 9345062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833.
    Jiang XR; Kelsey SM; Wu YL; Newland AC
    Br J Haematol; 1995 Jun; 90(2):375-83. PubMed ID: 7794760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH.
    Zacherl J; Hamilton G; Thalhammer T; Riegler M; Cosentini EP; Ellinger A; Bischof G; Schweitzer M; Teleky B; Koperna T
    Cancer Chemother Pharmacol; 1994; 34(2):125-32. PubMed ID: 7910786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of anti-Toxoplasma activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive and peptidyl-prolyl-isomerase-inhibiting activity: possible role of a P glycoprotein in Toxoplasma physiology.
    Silverman JA; Hayes ML; Luft BJ; Joiner KA
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1859-66. PubMed ID: 9303374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter.
    Loor F; Tiberghien F; Wenandy T; Didier A; Traber R
    J Med Chem; 2002 Oct; 45(21):4598-612. PubMed ID: 12361387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma.
    Pilarski LM; Belch AR
    Blood; 1994 Feb; 83(3):724-36. PubMed ID: 7507731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular levels of two cyclosporin derivatives valspodar (PSC 833) and cyclosporin a closely associated with multidrug resistance-modulating activity in sublines of human colorectal adenocarcinoma HCT-15.
    Uchiyama-Kokubu N; Watanabe T; Cohen D
    Jpn J Cancer Res; 2001 Oct; 92(10):1116-26. PubMed ID: 11676863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by rapamycin of P-glycoprotein 170-mediated export from normal lymphocytes.
    Yacyshyn BR; Bowen-Yacyshyn MB; Pilarski LM
    Scand J Immunol; 1996 Apr; 43(4):449-55. PubMed ID: 8668925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of P-glycoprotein by cyclosporin A analogues and metabolites.
    Demeule M; Laplante A; Sepehr-Araé A; Beaulieu E; Averill-Bates D; Wenger RM; Béliveau R
    Biochem Cell Biol; 1999; 77(1):47-58. PubMed ID: 10426286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potent immunosuppressive cyclosporin FR901459 inhibits the human P-glycoprotein and formyl peptide receptor functions.
    Tiberghien F; Wenandy T; Loor F
    J Antibiot (Tokyo); 2000 May; 53(5):509-15. PubMed ID: 10908115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of cyclosporin G (OG37-325), cyclosporin A, and their metabolites on the release of endothelin and prostacyclin from primary renal and aortic endothelial cell lines.
    Langman LJ; Yatscoff RW
    Ther Drug Monit; 1994 Oct; 16(5):450-7. PubMed ID: 7846742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bioassay for the activity of PSC 833 in human serum for modulation of P-glycoprotein-mediated multidrug resistance.
    Uchiyama-Kokubu N; Watanabe T; Nakajima M
    Anticancer Drugs; 2000 Aug; 11(7):583-90. PubMed ID: 11036963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-glycoprotein-mediated multidrug resistance is modulated by pretreatment with chemosensitizers in HCT-8 carcinoma cells in vitro.
    Haberl I; Swatonek H; Schaufler K; Ulsperger E; Wenzl E; Theyer G; Hamilton G; Thalhammer T
    Int J Oncol; 1998 May; 12(5):1137-42. PubMed ID: 9538140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in acute myeloid leukaemia.
    Grey M; Borg AG; Wood P; Burgess R; Fisher A; Yin JA
    Leuk Res; 1997 Sep; 21(9):867-74. PubMed ID: 9393602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport activity and surface expression of the Na+-Ca2+ exchanger NCX1 are inhibited by the immunosuppressive agent cyclosporin A and by the nonimmunosuppressive agent PSC833.
    Kimchi-Sarfaty C; Kasir J; Ambudkar SV; Rahamimoff H
    J Biol Chem; 2002 Jan; 277(4):2505-10. PubMed ID: 11700317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug binding to P-glycoprotein is inhibited in normal tissues following SDZ-PSC 833 treatment.
    Jetté L; Murphy GF; Béliveau R
    Int J Cancer; 1998 May; 76(5):729-37. PubMed ID: 9610733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.
    Dietel M; Herzig I; Reymann A; Brandt I; Schaefer B; Bunge A; Heidebrecht HJ; Seidel A
    J Cancer Res Clin Oncol; 1994; 120(5):263-71. PubMed ID: 7907333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of SDZ-PSC833 on daunorubicin intracellular accumulation in bone marrow specimens from patients with acute myeloid leukaemia.
    Merlin JL; Guerci AP; Marchal S; Bour C; Colosetti P; Kataki A; Guerci O
    Br J Haematol; 1998 Nov; 103(2):480-7. PubMed ID: 9827923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.